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Introduction
Mechanical loading of bone is of primordial importance for 
maintenance of bone. Muscle contractions, e.g. during loco-
motion enforce skeletal adaptation to the mechanical stimu-
lus and thus constitute a major determinant of bone metabo-
lism. Consequently disuse of the musculoskeletal unit during 
prolonged bed rest induces substantial loss in bone mass 
especially of the lower extremity1,2 that is mostly pronounced 
in the cortical section of the epiphyses3. At the metabolic 
level this seems to result from an imbalance of bone resorp-
tion and formation, described by a rapid increase in collagen 
breakdown products4-7 without any4,5,7,8 or with marginal 
changes9,10 in markers of bone formation. Current view sug-
gests Wnt signalling as potential link between mechanical 
unloading and related bone loss11. In keeping with this view, 
unloading elevates levels of circulating sclerostin12,13, the lat-
ter being a glycoprotein that has inhibitory effects on Wnt 
signaling in osteoblasts14.
Whilst the mechanisms of disuse-induced bone loss have 
been intensively studied in younger adults, little is known 
about adaptation of bone metabolism to disuse in older peo-
ple. Established evidence demonstrates a decline in bone 
mass and strength, an increase in fracture risk as well as a 
decrease in markers of bone turnover at old age in both sexes 
with similar patterns but differing progression15-19. Studies in 
rodents have shown that these age-related bone losses are 
associated with less osteoblastic differentiation potential and 
viability20. There may be more than one reason for this ob-
servation, such as the decline in sex steroids, secondary hy-
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perparathyroidism, vitamin D deficiency, somatopause and 
sarcopenia15. As muscle force and power, as well as physical 
activity decline with age, the question arises of whether the 
age-related decline in bone mass and strength is primarily 
related to reductions of the mechanical demands. If so, then 
one should expect that bone loss in response to bed rest is 
mitigated at old age, simply because the transition to bed 
rest should cause less disruption in people with lower levels 
of mechanical demands. Moreover disuse studies in rodents 
suggest that the osteogenic potential during disuse may be 
reduced with age as a consequence of less responsiveness 
to bone morphogenetic protein and IGF-121. However, to the 
best of our knowledge none of the very few immobilization 
studies in older people investigated bone metabolism22-24.
Current multi-disciplinary countermeasure research in 
the field of disuse-induced physiological phenomena’s, be-
sides exercise, focusses on nutrition and lately also involves 
stimulation of the central nervous system. Therefore a high-
protein diet was tested in the presented study in its potential 
to boost musculoskeletal recovery25. To lower the associated 
acidogenicity26 and maximize anabolic effects, the diet was 
alkalinized with potassium bicarbonate. During bed rest the 
study has included a cognitive training program as the pos-
sibility of a relatively direct interaction of the central nervous 
system with the musculoskeletal system has been raised27. 
For bone, specifically, there is a sound rationale for such di-
rect bone-brain interactions28,29.
Thus the main hypotheses of the presented study were that 
older people have reduced bone metabolism (H1), and that 
bone metabolism in older people would be less affected by 
experimental bed rest than in young (H2). Moreover, it was 
hypothesized that the countermeasure protocol affects bed-
rest induced changes in bone metabolism in older people (H3).
Materials and methods
Study design and setting
Eight healthy young males and 16 healthy older males 
participated in a 14-day horizontal bed rest study (Table 1). 
All men were Caucasians. The study was divided into three 3 
stationary study phases and an ambulatory follow-up phase: 
The stationary phases consisted of a 3-day baseline data 
collection phase (BDC), 14 days of bed rest (BR) and 2 days 
of stationary recovery (Rec). Throughout these periods the 
subjects were confined to the Valdoltra Orthopaedic Hos-
pital of Ankaran, Slovenia. During and after BR a combined 
countermeasure was assessed in the older subgroup in a 
randomized parallel design. Therefore after BDC the group of 
older subjects was randomly divided into one group that did 
BR only (N=8; O_BR), and one that did a combined counter-
measure (CMS) during and after BR (N=8; O_CMS). The CMS 
consisted of a daily cognitive training during BR and dietary 
protein plus alkaline supplementation during the first 28 
days of recovery. The group of young subjects did BR only 
(Y_BR). After 2 days of stationary recovery subjects were 
discharged from the clinic, but they returned at days 7, 14 
and 28 of recovery for follow-up measurements (Rec 7, 14 
and 28). During the whole period of 28 days of recovery, all 
subjects followed a physical rehabilitation programme with 
three weekly sessions of 60 minutes each. 
Biological endpoints of the presented study were biomark-
ers and regulators of bone metabolism as well as calcium and 
phosphate homeostasis. The study was conducted in accord-
ance with the ethical principles stated in the Declaration of 
Helsinki and it was approved by the Republic of Slovenia Na-
tional Medical Ethics Committee. Written informed consent 
was obtained from all volunteers prior to study start. 
Subjects
Study participants were recruited by advertisements 
in local newspapers and all applicants were examined pri-
or the study inclusion with an interview, routine blood and 
urine analysis, and a fitness battery test. Exclusion criteria 
were: smoking, regular alcohol consuming, history of deep 
vein thrombosis with D-dimer >500 μg·L-1; acute or chronic 
skeletal, neuromuscular, metabolic and cardiovascular dis-
ease condition; pulmonary embolism; a Short Physical Per-
formance Battery score<930. Body mass index at BDC was 
matched between young and old (P=0.861). After study com-
pletion the participants received a financial allowance.
Bed rest protocol
During BR subjects were constrained to bed 24h/day. 
Therefore all activities of daily living took place in bed. The 
protocol was performed in conformity with the European 
Space Agency’s bed rest standardization plan31, with the 
exception that subjects lay in a horizontal bed, rather than 
at -6° head down tilt. A maximum of one pillow was allowed 
for head elevation in any time of the BR period. Study par-
ticipants were under constant surveillance and provided with 
24-hour medical care and regular daily ward rounds. The 
bedrooms were air-conditioned and the room temperature 
was kept below 25°C. Every second day a physiotherapist 
performed a passive stretching. 
Interventions
Eight of the 16 older subjects did a combined counter-
measure (CMS) protocol consisting of a cognitive training 
and a nutritional intervention (O_CMS). The computerized 
cognitive training was applied daily from 2nd to 13th day of 
BR with 50 minutes of spatial navigation. Participants moved 
through the virtual environment using a joystick (Trust pred-
ator GM-2550) presented on a 17-inch LCD monitor situated 
approximately 60 cm in front of them. The training program 
consisted of virtual mazes representing a series of intercon-
nected corridors, with three available paths at each intersec-
tion. For each intersection, a pair of verbal or pictorial cues 
were displayed, placed at either opposite corner of the in-
tersection and in corridors at various non-decision-making 
points. After familiarization, participants were instructed to 
select the quickest (correct) path toward the finish line. The 
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training was performed using several virtual maze environ-
ments, each of increasing difficulty and length. 
The nutritional intervention was applied during station-
ary and ambulatory recovery up to 28 days after BR. It was 
composed of a hyperprotein bolus of 0.4 g whey protein/kg 
body weight/day for breakfast and 3 x 30 mmol potassium 
bicarbonate (KHCO3)/day.
Diet
Dietary intake was individually tailored and controlled 
during the entire stationary study period. Resting energy 
expenditure (REE) was calculated according to Harris and 
Benedict32 and multiplied by 1.4/1.2 (before/during BR) to 
account for physical activity and diet-induced thermogen-
esis. Macronutrient intake was kept constant with 55% of to-
tal energy intake being carbohydrates, 10-15% protein and 
25-30% fat. Individual menus for each subject were provid-
ed in form of standard hospital meals, individually weighted 
to meet the required energy and macronutrient intake. The 
diet excluded alcohol or methylxanthine derivates. Dietary 
intake was calculated using the Open Platform for Clinical 
Nutrition (OPEN) online recipe calculation method33, acces-
sible through the web site http://www.opkp.si/en_GB/cms/
vstopna-stran. The OPEN method relies on the procedure 
that was originally recommended by INFOODS34. 
Biological samples
24h urine collections and fasting blood samples were ob-
tained on the last days of BDC (BDC-2, BDC-1), and on days 2, 
5, 10 and 14 of BR, as well as on days 7 and 14 of Rec. After 
an overnight fast, blood samples were collected shortly after 
awakening from an antecubital vein through a short catheter 
into serum vacutainers® (BD, USA). Whole blood was centri-
fuged after coagulation (3000 rpm, 4°C) then serum was 
distributed into aliquots and immediately frozen at -20°C or 
-80°C until analysis. Urine aliquots were stored at -20°C un-
til analysis.
Biochemical analysis
Serum and urinary calcium and phosphate were analyzed 
by an automated analyzer (COBAS INTEGRA 400, Roche 
Diagnostics, Germany). All biomarkers and regulators of 
bone metabolism were analyzed by commercially available 
immunoassays in the laboratory of the Institute of Aero-
space Medicine, Germany. Biomarkers of bone formation 
(Procollagen type I N-terminal propeptide (P1NP), bone al-
kaline phosphatase (bAP)) as well as Parathyroid hormone 
(PTH) and 25-hydroxyvitamin d (25-OHD) were analyzed by 
radioimmunoassay (P1NP: RIA Orion Diagnostica, Finland; 
bAP: Immunotech, Czech Republic; PTH: Immunotech, Czech 
Republic; 25-OHD: Diasorin, USA). Inter- and intraassay 
variations were as follows: P1NP: 2.1%, 2.3%; bAP: 8.7%, 
4.8%; PTH: 5.3%, 6.2%; 25-OHD: 17%, 20.3%. Markers 
of bone resorption (Urinary C/N-telopeptide (UCTX/UNTX)) 
and further regulators of bone metabolism (Osteoprotegerin 
(OPG), soluble RANK ligand (sRANKL), Dickkopf-related pro-
tein 1 (DKK1), Sclerostin) were analyzed by enzyme-linked 
immunosorbent assay (UCTX/UNTX: Immunodiagnostic Sys-
tems, UK; OPG, sRANKL, DKK1: Biomedica, Vienna, Austria; 
Sclerostin: Quidel, San Diego, USA). Inter- and intraassay 
variations were as follows: UCTX: 6.8%, 5.9%; UNTX: 2.7%, 
1.2%; OPG: 3.7%, 2.9%; sRANKL: 6.2%, 1.0%; DKK1: 
3.3%, 3.4%; Sclerostin: both 2.1%. Samples of each sub-
ject were analyzed in one batch to avoid inter-assay variation 
within one subject. 
Statistical analyses
Statistical analyses were carried out using the R-environ-
ment in its version 3.1.1 for the 64-bit Windows platform 
(www.r-project.org). Data were analysed following the per-
protocol principle and are given as means and standard er-
rors (SE) in the figures and tables and as best linear unbiased 
predictors in the text. The level for statistical significance was 
set to α=0.05 and β was set to 0.2.
Linear mixed effect (LME) models with time and inter-
vention as fixed effects and subject as random effect were 
constructed in order to assess intervention effects. As the 
primary hypotheses of this study addressed age-related dif-
ferences in BR-induced responses, potential CMS-effects 
were of secondary priority in the statistical approach. Vari-
ances were allowed to differ between participants and inter-
vention, and LME models were optimized according to Akai-
ke’s information criterion (see p.353 and p.652 in35). Data 
were box-cox transformed where warranted by non-linear 
quantile-quantile plots or in case of heteroscedacity. Data 
from the baseline data collection phase (BDC) were lumped 
together, and so were data from the BR phase and from the 
recovery phase (Rec). Models were simplified in a step-wise 
manner, as long as P>β. Firstly, data from O_BR and O_CMS 
Groups were pooled to compare older versus young subjects 
(AgeGroup). Next, the Phase*Group interaction term, and 
then the Phase*AgeGroup term was deleted from the statisti-
cal model. The last step of model simplification was to delete 
AgeGroup from the model altogether, so that pure Phase ef-
fects were analyzed as the simplest model. Any significant 
effects were followed up with treatment contrasts, using BDC 
and O_BR as reference, or the older group where AgeGroup 
effects were assessed.
Results
Study conduct and subjects
23 subjects finished the protocol; one young subject 
dropped out on study day 1 due to second D-dimer values 
above 1500 μg·L-1. Overall, the 14 days of immobilization 
were well tolerated and none of the study finishers had ma-
jor difficulties in re-ambulation. The mean age-difference 
between the age groups was 37 years but body weight was 
nonetheless comparable (Table 1). According to reduced en-
ergy expenditure and intake with aging, calcium intake was 
approximately 150 mg lower in the older subjects compared 
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Figure 1. Urinary NTX excretion, serum concentrations of bone formation markers P1NP and bAP. Φ denotes significant main effects 
for phase, the reference level for contrasts being baseline (BDC); G denotes main effects for group with O_BR as reference for contrasts; 
iY_BR and iO_CMS denote phase*group interactions that were significant for the respective subgroups with BDC*O_BR used as contrast 
(***P<0.001, **P<0.01 and *P<0.05, respectively).
Table 1. Anthropometrics of test subjects at study entrance.
Age (years) Height (cm) Weight (kg) BMI (kg/m2)
Y_BR (n=7) 23 (3) 176.7 (6.6) 74.8 (8.8) 24.0 (2.4)
O_BR+O_CMS (n=16) 60 (2) 173.4 (4.9) 79.9 (12.3) 26.6 (4.4)
O_BR (n=8) 59 (3) 172.5 (4.0) 79.6 (10.5) 26.2 (4.8)
O_CMS (n=8) 60 (2) 174.3 (5.8) 80.3 (14.7) 26.4 (4.8)
Data are presented as mean (sd) for young (Y_BR) and older age groups and subgroups of the Older (O_BR, O_CMS).
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Figure 2. Serum concentrations of regulators of bone metabolism. Φ denotes significant main effect for phase with baseline (BDC) as 
reference for contrasts (***P<0.001 and *P<0.05, respectively).
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to the young subjects (Young: 790 mg (SD 79), Older: 655 
mg (SD 44)) and less than the recommended dietary allow-
ance of 800 mg/d36. Data collection was completed with 
the exception of missing voids for the 24h urine collections 
on days BDC-2, Rec+7, as well as for two subjects on day 
Rec+14. Data from these 24-hour collections were discarded 
from further analysis.
Biochemical markers of bone metabolism (Figure 1)
At baseline, urinary bone resorption markers and se-
rum bone formation markers where higher in young than in 
older subjects (CTX not shown). In both age groups bone re-
sorption markers were elevated during BR. Bone formation 
marker P1NP increased during recovery across age groups. 
However, both bone formation markers were affected by BR 
only in the Young (lower P1NP/higher bAP levels). The older 
subgroups depicted differing levels in CTX (O_CMS>O_BR) 
and bAP at baseline. 
Regulators of bone metabolism (Figure 2)
Sclerostin increased during BR and remained elevated 
during recovery across age groups. Besides, recovery was 
characterized by reduced levels of DKK1 and RANKL as well 
as elevated OPG levels (Note: statistical analysis was con-
ducted with n=6 for Y_BR, n=7 for O_BR and n=5 for O_CMS 
due to RANKL values beneath the biochemical detection 
limit). Consequently, the RANKL/OPG ratio was elevated dur-
ing recovery (not shown). No differences according to age 
groups were found.
Calcium and phosphate homeostasis (Figure 3)
At baseline, the young subjects started with higher 25-
OHD levels. Only their serum calcium levels increased dur-
ing BR and did not return to baseline levels within recovery. 
Serum phosphate and the serum calcium phosphate product 
(not shown) increased in both age groups during BR and re-
covery, PTH levels declined during BR. Urinary calcium ex-
cretion was only higher in O_CMS during BR (P<0.001, not 
shown) and no significant effects in urinary phosphate excre-
tion were found.
Discussion
The main aim of the present study was to compare bio-
chemical markers expression of bone metabolic responses to 
immobilization by BR in an older and younger group of men, 
as well as to study possible effects of a countermeasure in 
the older people. The main findings were: a) that older men 
had lower baseline levels of bone resorption markers, bone 
formation markers and 25-OHD; b) that despite the lower 
baseline levels in the older men, the increase in markers of 
bone resorption during BR was comparable among the age 
groups; c) that markers of bone formation were affected by 
BR in the young men, but not in the older. Across the age 
groups we found an activation of P1NP in the recovery pe-
riod, reflecting an increase in bone collagen synthesis, which 
was paralleled by reductions in circulating levels of the Wnt-
signaling marker DKK1 and the RANK/RANKL/OPG path-
way. Notably, there was no systematic effect of a cognitive 
training and nutritional countermeasure on bone metabolism 
in a subgroup of the older people assessed. 
General effects of age
The results of the presented study indicate a general re-
duction in overall bone turnover in healthy men around the 
age of 60. This seems to be independent from vitamin D de-
ficiency as 25OH-D levels of the older subgroup were well 
above the threshold for bone calcification processes of 40 
ng/mL37. These findings are in direct agreement with epide-
miologic studies in Caucasian men16,17,19,38,39 where reduced 
bone turnover with increasing age has been linked to fall-
ing levels in androgens and IGF-1. Only Szulc et al. observed 
higher levels of bone resorption in a subgroup of some men 
older than 6040. This imbalance in bone turnover was associ-
ated with lower BMD and may: a) be linked to general health 
status and b) constitute a relevant turning point in the pro-
gression of age-related bone loss and increasing fracture 
risk, respectively. 
Effects of un- and reloading on markers of bone metabolism 
and their control
Unaffected by differing baseline levels, markers of bone 
resorption increased in both age groups during BR. Markers 
of bone formation, however, were affected by disuse condi-
tions only in young men. As previously described in healthy 
young men during 60 days of BR41 we observed an increase 
in bAP and Sclerostin in the young subgroup within 14 days of 
immobilization. As apparent in Figure 2 and shown in former 
studies12,41, Sclerostin levels increased between day 11 and 
14, leading to respective reductions in osteoblast differentia-
tion (and circulating bAP levels) according to the long-term 
disuse data presented by Belavy et al.41. Hence differentia-
tion of osteoblasts, regulated by osteocytic Sost expression 
in healthy young men seems to adapt to mechanical unload-
ing and lower PTH levels within a couple of days, whereas ac-
cording to our data P1NP, reflecting bone collagen synthesis 
in mature osteoblasts, seems to be diminished by unloading 
rapidly in young people. 
Previous findings of elevated DKK1 levels during BR with 
-6° head-down tilt12 were not reproduced in this horizontal BR 
study. Furthermore there were no significant changes of the 
RANKL/OPG system observed during BR, and its crucial in-
volvement in disuse-induced bone losses in man with the age 
of 20-60 years therefore seems questionable. Nevertheless 
the present data are well compatible with an involvement of 
OPG and of the RANKL/OPG ratio in modulating bone resorp-
tion after reloading. Additionally DKK1 levels were reduced 
below baseline levels during the 14 days of re-ambulation, 
and bone collagen synthesis was simultaneously intensified 
compared to baseline.
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Figure 3. Parameters of calcium and phosphate homeostasis. Φ denotes significant main effect for phase (reference level: BDC); G 
denotes a main effects for group (reference level: O_BR); and iO_CMS denotes a phase*group interaction that was significant the respec-
tive subgroups with BDC*O_BR used as contrast (***P<0.001, **P<0.01 and *P<0.05, respectively).
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Age-related effects of immobilization
BR elicited substantial increases in bone resorption mark-
ers which were comparable across age groups in absolute 
terms. These are well-known adaptations of the mature hu-
man skeleton to mechanical unloading4-6,9,10,12, which are con-
firmed for the first time for the male senile human skeleton. 
On the other hand neither P1NP nor bAP were affected by 
BR in the older men, although the increase in Sclerostin was 
apparent across both age groups. This may indicate an al-
tered antagonistic influence of Sclerostin to the Wnt pathway 
and thus, a reduced mechano-sensitivity of bone formating 
processes with ageing. Re-ambulation, however, appeared to 
affect DKK1, the RANKL/OPG system as well as P1NP in the 
older just as in the young men. Thus, the imbalance of bone 
resorption and formation during BR appears to be diminished 
in the older men, and all groups seemed to readily respond 
to the mechanical stimuli associated with the re-ambulation. 
Taking bone resorption and bone formation responses to-
gether, the present data suggest a small ‘sparing’ effect for 
immobilization-induced bone losses at old age, which would 
depend on sparing of the bone formation depression. In con-
sequence, the present bone metabolism data do not support 
the often-heard notion that immobilization would be more 
deleterious in older people than in younger people.
Calcium and phosphorus homeostasis
As previously observed in other studies, BR elicited modest 
increases in serum levels of calcium and phosphate as well as 
decreases in PTH12,42. It seems evident that bone resorption 
challenges calcium homeostasis in the serum and other body 
fluids, and serum PTH is a key player in the control of serum 
Ca++ concentration, at least within the physiological range43. 
Thus, serum PTH should decrease as a secondary response to 
the primary elevation of Ca++ levels resulting from the disuse-
induced increase in bone resorption. In addition, the younger 
subjects had higher 25-OHD serum levels at baseline, and 
this is the likely explanation for the greater increase in serum 
calcium levels during BR than in the older groups. As expected 
serum phosphate levels were concomitantly increased during 
BR, which was observed in all three groups to a very similar 
extent. However, the continued increase of phosphate during 
the entire 14 days of follow-up is very surprising, even more 
so as PTH is not decreased during the follow-up phase, and 
since it is therefore unlikely that the effect is engendered by 
renal conservation of phosphate alone.
Effects of cognitive training and nutritional countermeasure
As a combined countermeasure protocol was foreseen 
for the study, we additionally analyzed the impact of cogni-
tive training and nutrition on bed-rest induced changes in 
bone metabolism in older people. There were a few salient 
differences between the two groups of older subjects. These 
encompassed a greater urinary CTX excretion in the coun-
termeasure group (O_CMS) at baseline, a greater calcium 
excretion during BR, levated bAP at baseline and reduced 
bAP levels during recovery. These differences between the 
subgroups may suggest that the countermeasure not only 
failed to protect bone during BR, but that it might actually be 
rather counterproductive. However, the fact that CTX values 
were greater already at baseline, i.e. when the countermeas-
ure protocol had not even started, likely suggests that the 
differences between O_BR and O_CMS groups in this study 
are caused by random variation between subjects. 
Limitations
‘The elderly’ represents a very heterogeneous group con-
cerning morbidity and functionality, which makes it difficult 
to study pure aging processes in humans. We studied a small 
subgroup of older men who were at a good state of health 
and sufficient in vitamin D in order to reduce side effects in 
addition to the ageing process on bone turnover. However, 
the subjects were rather ‘young’ older people (55-65 years) 
whose ageing processes may be less pronounced than in 
people advanced in years. Furthermore the BR period of 2 
weeks was too short to study morphologic changes and de-
flect bone mass changes or fracture risk, so that the present 
conclusions are limited to assessment of circulating markers 
of bone metabolism. The former should be addressed in fur-
ther long-term observations.
Conclusion
From the obtained results we conclude that in men age-
ing is characterized by a reduction in bone turnover inde-
pendently from vitamin D deficiency. Unlike bone resorption, 
bone formation appeared to be less responsive to mechanical 
unloading in men with older age, suggesting that bone loss in 
the long run would be less pronounced than in younger peo-
ple. This however needs to be confirmed by morphological 
analyses after longer periods of disuse. 
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